Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV
Title in Portuguese as published on TED.
Contract award notice published on TED on 1 Jun 2026 by Instituto Português de Oncologia do Porto Francisco Gentil, EPE (Portugal), CPV 33600000 Pharmaceutical products. Awarded to GlaxoSmithkline - Produtos Farmacêuticos, Lda. for EUR 100.
| Notice | 370892-2026 (can-standard) |
|---|---|
| Status | Contract award |
| Published | 1 Jun 2026 |
| Buyer | Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto |
| Country | Portugal |
| Main CPV | 33600000-6 Pharmaceutical products |
| Contract type | supplies |
| Procedure | restricted |
| Awarded value | EUR 100 |
| Tenders received | 1 |
| Award decision | 15 May 2026 |
Daily EU tender alerts
Basic $19 a month, up to 5 filters. Pro $49 a month, up to 30 filters and tenders closing within 5 days. Charged in UAH at the National Bank of Ukraine rate on the payment day.
Description
Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV
Lots (1)
| Lot | Title | Estimated value | Deadline |
|---|---|---|---|
| LOT-0000 | DOSTARLIMAB 50 MG/ML SOL. INJ. FRS 10 ML IV |
Winners
- GlaxoSmithkline - Produtos Farmacêuticos, Lda. Oeiras, Portugal
More Pharmaceutical products in Portugal
Get new pharmaceutical products tenders by email
A free weekly digest of new competition notices from TED. One-click unsubscribe in every email.
Daily EU tender alerts
Basic $19 a month, up to 5 filters. Pro $49 a month, up to 30 filters and tenders closing within 5 days. Charged in UAH at the National Bank of Ukraine rate on the payment day.